News | RIVM

Not yet fully vaccinated against HPV? Do not postpone any longer!

Time is running out for those who have not yet had the HPV vaccine, but do want to get it.

Last chance for young adults to get vaccinated against HPV for free

Today sees the launch of the ‘Do not miss out’ campaign, which calls on young people to get the first dose of the vaccine against the human papillomavirus (HPV) as soon as possible.

Drop in and get vaccinated without an appointment on HPV Awareness Day

Saturday 4 March is HPV Awareness Day. It is a day to stop and think about the human papillomavirus (HPV) and the six kinds of cancer it can cause. These cancers affect both men and women.

More than two million invitations to get vaccinated against HPV in 2023

In early 2023, 1.3 million young adults will receive an invitation to get vaccinated against the human papillomavirus (HPV). This group comprises around 900,000 men and 400,000 women between the ages of 19 and 27.

Almost half of 9 and 10-year-olds get HPV vaccination at first opportunity

This spring, more than 800,000 young people received an invitation to be vaccinated against HPV, the human papillomavirus.

RIVM expands HPV vaccination programme: girls and boys protected from six types of cancer with one vaccine

Now not only girls, but also boys will have the opportunity to protect themselves from cancer caused by HPV.

Jongen en meisjes poseren op een kruk voor campagneposter HPV vaccin

State Secretary Blokhuis: boys will also be vaccinated against HPV virus

The vaccine against the HPV human papillomavirus virus will also become available for boys.

Research: HPV vaccine is safe

RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.

Vaccination rate again drops slightly, HPV vaccination rate drops considerably

The vaccination rate for vaccines included in the National Immunisation Programme has dropped slightly by about 1 percent.

Risks of potential release of genetically modified mosquitoes evaluated

On Saba, a Dutch Caribbean island, diseases such as dengue, chikungunya and zika can be reduced by the use of genetically modified mosquitoes.